Related Experiment Video

Updated: Jun 17, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Coronary stents and noncardiac surgery: current clinical challenges and conundrums

Jagtar S Heir1, Vijaya Gottumukkala, Manmeet Singh

  • 1Department of Anesthesiology and Perioperative Medicine, The University of Texas M D Anderson Cancer Center, Houston, TX, USA. jsheir@mdanderson.org

Preventive Cardiology
|December 22, 2009
PubMed

Insights

Patients with drug-eluting stents (DES) face perioperative myocardial infarction risks despite antiplatelet therapy. Enhanced perioperative care protocols are crucial for managing these high-risk surgical patients.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Cardiovascular Surgery

Background:

  • Patients undergoing percutaneous transluminal coronary angioplasty with drug-eluting stent (DES) placement present unique perioperative challenges.
  • Current antiplatelet regimens may not fully mitigate the risk of perioperative myocardial infarction in these individuals.

Observation:

  • Drug-eluting stent (DES) recipients remain at risk for stent thrombosis and myocardial infarction during the perioperative period.
  • Perioperative myocardial infarction carries significant morbidity and mortality.

Findings:

  • Adherence to current antiplatelet guidelines does not eliminate the risk of perioperative myocardial infarction in patients with recent DES placement.
  • Stent thrombosis is a critical concern in the perioperative management of these patients.

Implications:

  • There is a need for clear, evidence-based guidelines for the perioperative management of surgical patients with prior DES placement.
  • Multidisciplinary collaboration among cardiologists, anesthesiologists, and surgeons is essential to optimize patient outcomes.
  • Further research is warranted to refine antiplatelet strategies and perioperative care for this vulnerable patient population.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...